Sail Biomedicines

Drug Discovery · Biotechnology
Sponsors visas
8Open roles1 posted in 30 days
$115kMedian advertised pay$100k – $150k−7% vs market
112 daysTime to fillmedian of 5 closed rolesmarket: 36 days
Lately:2 news stories in 90 daysFollow changes →

Facts

as of Nov 17, 2026

Charting a new course. Sail Biomedicines was formed in October 2023, uniting first-in-category technologies developed in Flagship Labs. Sail’s platform..

It is hiring: 8 open roles, 1 of them posted in the last 30 days.

Open roles
8Alion job postings
Website
sail.bio

As of Nov 17, 2026, Alion lists 8 open roles at Sail Biomedicines. The median pay stated in its open roles is $105k, across 8 postings that state pay.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Hiring slowly: few roles were posted lately.

Science & Research is the largest family, 78 of open roles.

1Posted in 30 days13% of open roles are fresh
0%Remote roles0 of 8
1Hiring offices
Can they hire you from United States?by your location
Likely
13 open roles are in your country: you apply locally, no move needed.
United States13On site
Remote, from elsewhere0Rare
No posting offers visa sponsorship. Remote roles: 0.
Time to fillmedian days to close a role
Sail Biomedicines112 days
Market, same roles36 days
Alion signals0-100
Demand18
Pay41
Your chance48
How badly they need people, whether they pay, how realistic getting in is.
Open roles over time−100%
Sep 21This week
Open roles a week: 11 then, 0 now
Where the openings areshare of open roles · trend
Science & Research78▼
Biotech22▲
Newest roles
Senior Scientist I, Computational Biology
$130k – $170k per year · In office · 3+ years exp · PhD · Cambridge
Scientist I/Senior Engineer I, Pilot Lab Lead
$100k – $150k per year · In office · 8+ years exp · Bachelor's Degree · Cambridge
Research Associate I/Research Associate II, Preclinical Manufacturing
$75k – $100k per year · In office · 2+ years exp · Cambridge
Senior Scientist I, Analytical Sciences
$125k – $175k per year · In office · 9+ years exp · PhD · Cambridge
Degree asked
Bachelor's Degree 57%Doctoral Degree (PhD) 43%
7 postings state a degree.
Benefits named in postingsshare of open roles
Professional development113%
Visa sponsorship: none statedRelocation: none stated
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family

What its postings pay, by level.

$115kMedianmarket estimate $113k
$100k – $150kTypical rangeUSD a year
$175kHighest paying roleSenior Scientist I, Analytical Sciences
Pay by levelmiddle half of stated pay, median marked · dashed: market median $113k
Senior6$105k$100k – $125k
$0$38k$75k$113k$150k
Source: the pay stated in the company's postings, normalised to USD a year

Named in the work visa registers of United States.

United StatesUS 2 #4,273 of 8,997 sponsors
2H-1B filings in 12 months
$88kMedian offered salary
8Open roles in United States
Who they sponsor
Medical scientists1
Biological technicians1
The salary offered for each occupationVisa pass · 90 credits

In the register as Sail Biomedicines, Inc., Cambridge, MA

Other sponsors in the same field
See 8 open roles Alert me
US Department of Labor · latest filing Apr 10, 2026

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
CambridgeBusiest site
SiteTypeOpen rolesHires most forEngineering
Cambridge United StatesEngineering / R&D8Science & Research, Biotech75%
Source: office addresses in postings and company registers

Peers

Ranked #3 by open roles among its 11 closest peers.

#CompanyHQOpen rolesSize
1Women In BioSan Francisco, United States58
2Parabilis MedicinesCambridge, United States1451-200
3Sail BiomedicinesCambridge, United States8
4Treeline BiosciencesWatertown, United States8201-500
5ProsettaSan Francisco, United States-
6Reaction BiologyMalvern, United States-
7AiViva BioPharmaNewport Beach, United States-11-50
8Biosensing InstrumentTempe, United States-11-50
Source: Alion's similar-companies engine (industry segments, technologies, headquarters country, size)

Technologies named in job postings at Sail Biomedicines over the last 12 months, by layer, with the share of postings for each.

17Technologies in use
12Postings analysed
56/100Stack modernity
LanguagesPython 17%
Sign in to see how your skills match this stackSign In
Full Sail Biomedicines tech stack17 technologies · by team · pay by technology · changes · similar stacks
Source: the technologies named in the company's postings and on its site

Milestones

Each milestone is dated by its source: registers, filings, the press

Newsroom

Sep 292026
News · pharmexec.com
Vincent Hennemand discusses using these types of therapies to develop treatments for autoimmune conditions.
Sep 292026
News · pharmexec.com
Johnson & Johnson moves to acquire Sail Biomedicines, Processa acquires Vidya Therapeutics, and Relation partners with GSK on AI-driven target discovery collaboration.
Aug 22026
News · Pulse 2.0
Johnson & Johnson has entered into strategic agreements with Sail Biomedicines to develop in vivo CAR-T therapies for immune-mediated diseases and has secured an exclusive option…
Jul 312026
News · pharmabiz.com
J&J collaborates with Sail Biomedicines to advance in vivo CAR-T programmes and transform autoimmune disease via immune reset
Jul 302026
News · YahooFinance
CAMBRIDGE, Mass., July 29, 2026--Sail Biomedicines Announces Strategic Collaboration to Develop New Class of Medicines for In Vivo CAR-T
Apr 272026
News · YahooFinance
CAMBRIDGE, Mass., April 27, 2026--Sail to Present Preclinical Data Supporting Advancement of Its In Vivo eRNA CAR-T Product Candidate to the Clinic at ASGCT 2026 and TIDES USA 2026
Sources: the outlets named on each headline, each story once